Q2 2019 13F Holders as of 6/30/2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
19.2M
-
Shares change
-
+2.88M
-
Total reported value, excl. options
-
$497M
-
Value change
-
+$81.1M
-
Number of buys
-
57
-
Number of sells
-
-26
-
Price
-
$25.98
Significant Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2019
87 filings reported holding CDLX - Cardlytics, Inc. - Common Stock, par value $0.0001 as of Q2 2019.
Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2M shares
of 53M outstanding shares and own 36.11% of the company stock.
Largest 10 shareholders include FMR LLC (3.39M shares), Polaris Venture Management Co. V, L.L.C. (2.28M shares), CAS Investment Partners, LLC (2.16M shares), JENNISON ASSOCIATES LLC (1.18M shares), Canaan Partners VIII LLC (1.13M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.05M shares), BlackRock Inc. (904K shares), VANGUARD GROUP INC (755K shares), CANNELL CAPITAL LLC (627K shares), and Grantham, Mayo, Van Otterloo & Co. LLC (400K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.